Eli Lilly ( LLY 0.89%) has been growing its sales at a good clip over the past year. This is partly thanks to Zepbound, a ...

Pharmaceutical giant Eli Lilly (LLY) surged 14% last week to $840 per share following positive Phase 3 trial results for its ...

Eli Lilly (NYSE:LLY) experienced a 2% decline last week, a movement that contrasts with a broader market drop of 3%. The ...

We recently published a list of the 13 Best American Dividend Stocks to Buy According to Analysts. In this article, we are ...

When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects.

We recently published a list of the 10 Best Long Term Stocks to Buy According to Billionaires. In this article, we are going ...

We recently published a list of the 13 Best American Dividend Stocks to Buy According to Analysts. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY ...

Eli Lilly reports positive late-stage data for its weight-loss pill. BMO analyst says Lilly's update will weigh on shares of ...

Eli Lilly benefits from rising cash flow and a strong pipeline, yet elevated pricing versus peers limits near-term gains. See ...

VIG's Index rebalanced last week and now counts Eli Lilly as its #5 holding with a 3.45% allocation. The ETF is on an impressive 11-year dividend growth streak. The Index yield dropped 0.04% to 1. ...

But it comes with risks, as its business has been struggling to grow in recent years, and its rate of dividend increases has been modest. Meanwhile, pharma company Eli Lilly (NYSE: LLY ...